Redeye tweaks its estimates amid higher ASP and lower volume than expected, resulting in ~7% lower H...
Mostly spare parts remain in Russian inventory Sales and earnings drop-off expected from Q3 German...
Det andra kvartalet har präglats av låg riskvilja och ett återhållsamt klimat för kapitalanskaffning...
Redeye states that Catella’s Q2 report was even stronger than expected.
Redeye’s view on the case remains intact and our forecasts on group level are virtually unchanged.
Based on segment reporting, Taaleri reported Q2 sales of EUR 11.
Redeye raises its forecasts and Base Case slightly following a Q2 report beating our forecasts somew...
EBITA +77% vs. ABGSCe, 20% organic growth Positive wording around M&A Share trades at 9.
DevPort levererar ytterligare ett imponerande kvartal med hög organisk tillväxt under god lönsamhet.
Säsongsmässigt svagt kvartal Omsättningen i Q2'22 uppgick till EUR 11,3m (EPB EUR 12,4m).
EQL Pharma fortsätter växa kärnverksamheten i hög takt där tillväxten uppgick till 33 procent för kv...
Redeye sees no big surprises in the Q2 report as activities overall seem to progress according to pl...
Tuffare omvärld tynger annonsmarknaden Totala intäkter för Q2 var 33 mkr, vilket var 8% lägre y/y.
Den organiska tillväxten imponerar... Omsättningen uppgick till 664 mkr (EPB 630 mkr), motsvarande e...
Redeye’s expectations were only slightly higher than reported Q2 numbers on group level.
Redeye will likely increase its forecasts slightly following a solid Q2 report showing accelerating ...
EcoRub meddelade den 18 augusti att bolaget lanserar EcoTPEsuperTM vilket är ett unikt cirkulärt alt...
Dovre’s Q2 EBIT came in above our estimate due to Project Personnel.
Redeye raises its full-year sales estimates for 2022E from EUR 7.
Redeye comments on Imint's Q2 report, which was more or less in line with our estimates.
